Sign Up to like & get
recommendations!
1
Published in 2017 at "International Journal of Applied and Computational Mathematics"
DOI: 10.1007/s40819-016-0223-2
Abstract: The present investigation is dealt with the effect of interstrut distance on the transport and retention of drug eluted from a well-apposed drug-eluting stent (DES). We consider a two-species model (free and bound), capable of…
read more here.
Keywords:
drug;
drug retention;
distance transport;
interstrut distance ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Seminars in arthritis and rheumatism"
DOI: 10.1016/j.semarthrit.2020.09.014
Abstract: OBJECTIVES To assess drug retention rates (DRRs) and reasons for discontinuation of biologic disease-modifying antirheumatic drugs (bDMARDs) in a large monocentric cohort of patients with adult onset Still's disease (AOSD). METHODS Clinical data of AOSD patients…
read more here.
Keywords:
onset still;
adult onset;
drug retention;
retention rates ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-01132-6
Abstract: The clinical data on the biologic disease-modifying antirheumatic drug (bDMARD) use in late-onset ankylosing spondylitis (LOAS) is limited. Thus, this study aimed to evaluate the drug efficacy and retention rate of bDMARDs in LOAS and…
read more here.
Keywords:
ankylosing spondylitis;
drug retention;
disease;
onset ankylosing ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000031161
Abstract: In this retrospective cohort study, we compared the retention rates and effectiveness of biologic disease modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs (targeted disease modifying antirheumatic drug [tsDMARDs]: Janus kinase inhibitors [JAKi]) in elderly…
read more here.
Keywords:
drug retention;
group;
bdmards jaki;
elderly patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.3236
Abstract: Background Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis (RA) is about 60-70% in real life at one year1. In France, all biologics 1st prescription and yearly renewal are reimbursed, restricted…
read more here.
Keywords:
retention rate;
drug retention;
tcz;
drug ... See more keywords